Education
About Us
Working with TipRanks
Follow Us
Tanvex Biopharma Inc (TANVF)
OTHER OTC:TANVF
TANVF Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
TANVF FAQ
What was Tanvex Biopharma Inc’s price range in the past 12 months?
Currently, no data Available
What is Tanvex Biopharma Inc’s market cap?
Tanvex Biopharma Inc’s market cap is $404.98M.
When is Tanvex Biopharma Inc’s upcoming earnings report date?
Tanvex Biopharma Inc’s upcoming earnings report date is Mar 13, 2026 which is in 27 days.
How were Tanvex Biopharma Inc’s earnings last quarter?
Tanvex Biopharma Inc released its earnings results on Nov 12, 2025. The company reported -$0.036 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.036.
Is Tanvex Biopharma Inc overvalued?
According to Wall Street analysts Tanvex Biopharma Inc’s price is currently Undervalued.
Does Tanvex Biopharma Inc pay dividends?
Tanvex Biopharma Inc does not currently pay dividends.
What is Tanvex Biopharma Inc’s EPS estimate?
Tanvex Biopharma Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tanvex Biopharma Inc have?
Tanvex Biopharma Inc has 264,956,360 shares outstanding.
What happened to Tanvex Biopharma Inc’s price movement after its last earnings report?
Tanvex Biopharma Inc reported an EPS of -$0.036 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Tanvex Biopharma Inc?
Currently, no hedge funds are holding shares in TANVF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Tanvex Biopharma Inc
Tanvex BioPharma Inc is a biopharmaceutical company. It is engaged in research, development, manufacture, and sale of biosimilar products. The company's products are used to cure diseases such as Neutropenia, Breast Cancer, Metastatic Colorectal Cancer, and others.
ADMA Biologics
―
ANI Pharmaceuticals
―
Eagle Pharmaceuticals
―
Crinetics Pharmaceuticals
―
Regeneron
―
Incyte
―